From Discovery to Clinical Impact: AACR Special Conference Captured the Spectrum of Lymphoma Research
At the AACR Special Conference on Advances in Malignant Lymphoma, Ronald Levy, MD, FAACR, of Stanford University, discussed...
At the AACR Special Conference on Advances in Malignant Lymphoma, Ronald Levy, MD, FAACR, of Stanford University, discussed...
During the second quarter of 2026, oncology approvals issued by the U.S. Food and Drug Administration expanded the treatment...
In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
In the last quarter of 2025, the FDA announced 20 approvals in oncology, including treatments for lung cancer, multiple...
This month, the editors of AACR’s journals picked studies highlighting genetic parallels between cancer evolution and high-altitude physiology, data...
Our immune systems are equipped to recognize and destroy cancer cells—if they can find them, that is. And with...
Editor’s Note: Raquel Castellanos is assistant director of Scientific Programs at the American Association for Cancer Research. She and...
Twenty-one years ago this week, police officers, firefighters, paramedics, and volunteers converged on the remains of the World Trade...
From June 23-26, researchers from around the world will gather in Boston for the Third AACR International Meeting on...
What if a machine could “think” like a doctor and diagnose and treat a disease? This is one of the long-term goals for the...